Larner College of Medicine

Vermont Academic Detailing Program

Group of clinicians around a table

Vermont Academic Detailing Program

The Vermont Academic Detailing Program is a university-based prescriber education and support program. Faculty review clinical topics, focusing on the latest evidence for lifestyle changes, generic medications, and new drug releases. This information is shared with healthcare teams across Vermont.

Program Overview

Body

Vermont Academic Detailing Program is offered by the University of Vermont’s Office of Primary Care with funding from public and private sources, including the State of Vermont. There is no pharmaceutical company sponsorship associated with the Vermont Academic Detailing Program nor do the program faculty have any ties to the pharmaceutical industry. The faculty objectively review clinical topics, covering the latest evidence for lifestyle changes and generic medications in addition to the latest in medication releases. This information is shared with health care teams across Vermont.

The goal of the Vermont Academic Detailing Program is to promote high quality, evidence-based, patient-centered, and cost-effective treatment decisions by health care professionals.

Scheduling and Other Information

Body

These free programs offer prescribers CME credit to prescribers (physicians, physician assistants, nurse practitioners, and naturopaths), pharmacists, and nurses, and can be scheduled as small group or one-on-one sessions in your office for any of these topics; we also offer "live" sessions virtually on Zoom. 

To achieve our goals, we rely on the guidance and broad opinions of multiple stakeholders. We have formalized these stakeholders as Vermont Academic Detailing Program Advisors. The role of the Program Advisor is to provide opinions and practical advice regarding the approach, direction, and operation of the Vermont Academic Detailing Program.

For more information about academic detailing beyond Vermont, please visit the National Resource Center for Academic Detailing (NaRCAD).

Program Coordinator

Alicia Poquette
Interim Program Coordinator
Email: alicia.poquette@uvm.edu / Phone: 802-656-9297

Sign Up for a Session

Body

Sign up for a session online or contact the Vermont Academic Detailing Program Coordinator to schedule a session:

Alicia Poquette
Interim Program Coordinator
Email: alicia.poquette@uvm.edu / Phone: 802-656-9297

Current Academic Detailing Session Topics

Management of Migraines
Body

This session highlights the practical aspects of managing migraines in primary care, with a focus on the available evidence-base. The session includes discussion of non-pharmacologic and pharmacologic approaches and includes patient evaluation tools and resources for patient education.

Updates in Infectious Disease: HIV Pre-Exposure Prophylaxis | Hepatitis C (Two Part Series))
Body

Part A:Updates in Infectious Disease: HIV Pre-Exposure Prophylaxis (PrEP)

Part B: Updates in Infectious Disease: Hepatitis C

These sessions highlight the aspects of HIV pre-exposure prophylaxis and hepatitis C treatment in primary care, with a focus on the available evidence-base. The sessions include information about epidemiology and related statistics, information on taking a sexual history and substance use disorder history, and discusses the risks and benefits of various medication options. The sessions also include resources for patient education. 

Management of Obesity
Body

This session highlights the practical aspects of managing obesity in primary care, with a focus on the available evidence‐base. This session includes information about epidemiology and related statistics, body mass index, obesity as a chronic illness, evidence for non-pharmacologic approaches, and discusses the risks and benefits of various medication options. The session also includes resources for patient education.

Preventing and Managing Alcohol Use Disorder
Body

This session highlights the practical aspects of preventing and managing alcohol use disorder in primary care, with a focus on the available evidence‐base. This session includes information about alcohol epidemiology and related statistics, prevention of alcohol use disorder, diagnosis of alcohol use disorder, and discusses the risks and benefits of various treatment options. The session also includes resources for patient education.

Management of Fibromyalgia (Qualifying Controlled Substance CME Activity)
Body

NOTE: This session is a qualifying CME activity related to the topic of safe and effective prescribing of controlled substances required by the Vermont Board of Medical Practice.

This topic includes reviewing the diagnosis of fibromyalgia, evaluating the evidence for non-pharmacologic management options, and discussing the pharmacologic approaches to management.

Management of Opioids in Primary Care (Qualifying Controlled Substance CME Activity)
Body

NOTE: This session is a qualifying CME activity related to the topic of safe and effective prescribing of controlled substances required by the Vermont Board of Medical Practice.

This session highlights the practical aspects of managing patients prescribed opioids in primary care. This session includes reviewing the rules for both prescribing and querying the Vermont Prescription Monitoring System (VPMS). This session includes information about how to safely initiate and discontinue opioids in primary care.

Management of Type 2 Diabetes
Body

This session highlights the new, non-insulin medications for managing patients with type 2 diabetes in primary care, with a focus on the available evidence‐base related to cardiac and other outcomes. This session also includes information about nutrition and lifestyle, insulin safety, and recommendations from the American Diabetes Association guidelines.